Your browser doesn't support javascript.
Predicting COVID-19 progression from diagnosis to recovery or death linking primary care and hospital records in Castilla y León (Spain).
Álvarez-Esteban, Pedro C; Del Barrio, Eustasio; Rueda, Oscar M; Rueda, Cristina.
  • Álvarez-Esteban PC; Department of Statistics and Operations Research, Universidad de Valladolid, Valladolid, Spain.
  • Del Barrio E; Department of Statistics and Operations Research, Universidad de Valladolid, Valladolid, Spain.
  • Rueda OM; MRC-Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Rueda C; Department of Statistics and Operations Research, Universidad de Valladolid, Valladolid, Spain.
PLoS One ; 16(9): e0257613, 2021.
Article in English | MEDLINE | ID: covidwho-1430545
ABSTRACT
This paper analyses COVID-19 patients' dynamics during the first wave in the region of Castilla y León (Spain) with around 2.4 million inhabitants using multi-state competing risk survival models. From the date registered as the start of the clinical process, it is assumed that a patient can progress through three intermediate states until reaching an absorbing state of recovery or death. Demographic characteristics, epidemiological factors such as the time of infection and previous vaccinations, clinical history, complications during the course of the disease and drug therapy for hospitalised patients are considered as candidate predictors. Regarding risk factors associated with mortality and severity, consistent results with many other studies have been found, such as older age, being male, and chronic diseases. Specifically, the hospitalisation (death) rate for those over 69 is 27.2% (19.8%) versus 5.3% (0.7%) for those under 70, and for males is 14.5%(7%) versus 8.3%(4.6%)for females. Among patients with chronic diseases the highest rates of hospitalisation are 26.1% for diabetes and 26.3% for kidney disease, while the highest death rate is 21.9% for cerebrovascular disease. Moreover, specific predictors for different transitions are given, and estimates of the probability of recovery and death for each patient are provided by the model. Some interesting results obtained are that for patients infected at the end of the period the hazard of transition from hospitalisation to ICU is significatively lower (p < 0.001) and the hazard of transition from hospitalisation to recovery is higher (p < 0.001). For patients previously vaccinated against pneumococcus the hazard of transition to recovery is higher (p < 0.001). Finally, internal validation and calibration of the model are also performed.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Primary Health Care / Hospital Records / Disease Progression / COVID-19 / Hospitals Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Europa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0257613

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Primary Health Care / Hospital Records / Disease Progression / COVID-19 / Hospitals Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Europa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0257613